These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2476512)

  • 1. Dipyridamole potentiates the growth-inhibitory action of methotrexate and 5-fluorouracil in human keratinocytes in vitro.
    Schwartz PM; Milstone LM
    J Invest Dermatol; 1989 Oct; 93(4):523-7. PubMed ID: 2476512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
    Zhen YS; Taniki T; Weber G
    Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells.
    Cabral S; Leis S; Bover L; Nembrot M; Mordoh J
    Proc Natl Acad Sci U S A; 1984 May; 81(10):3200-3. PubMed ID: 6587345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole.
    Van Mouwerik TJ; Pangallo CA; Willson JK; Fischer PH
    Biochem Pharmacol; 1987 Mar; 36(6):809-14. PubMed ID: 3566784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical modulation of fluorouracil by dipyridamole: preclinical and clinical experience.
    Grem JL
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):56-65. PubMed ID: 1557658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate.
    Bowen D; Bailey BD; Guernsey LA
    Eur J Cancer Clin Oncol; 1984 May; 20(5):651-7. PubMed ID: 6234172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B: a biological response modifier in targeting against the salvage pathways.
    Zhen YS; Reardon MA; Weber G
    Biochem Pharmacol; 1987 Nov; 36(21):3641-6. PubMed ID: 3675621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
    Cole PD; Smith AK; Kamen BA
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hypoxanthine and thymidine in determining methotrexate plus dipyridamole cytotoxicity.
    Chan TC; Howell SB
    Eur J Cancer; 1990; 26(8):907-11. PubMed ID: 2171601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line.
    Grem JL; Mulcahy RT; Miller EM; Allegra CJ; Fischer PH
    Biochem Pharmacol; 1989 Jan; 38(1):51-9. PubMed ID: 2462882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the discrepant effect of a combination of methotrexate plus dipyridamole on human hematologic cell lines.
    Hirose M; Takeda E; Kuroda Y
    Jpn J Clin Oncol; 1993 Aug; 23(4):232-7. PubMed ID: 8411736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azidothymidine inhibition of thymidine kinase and synergistic cytotoxicity with methotrexate and 5-fluorouracil in rat hepatoma and human colon cancer cells.
    Weber G; Ichikawa S; Nagai M; Natsumeda Y
    Cancer Commun; 1990; 2(4):129-33. PubMed ID: 2369552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipyridamole mediated enhanced antiproliferative activity of 10-ethyl-10-deazaaminopterin (10-EDAM) against human lung cancer cell lines.
    Dearing MP; Englee-Miller MJ; Kratzke RA; Kramer BS; Chu E; Weinstein J; Anderson M; Venzon D; Mulshine JL; Gazdar AF
    J Cell Biochem Suppl; 1996; 24():165-72. PubMed ID: 8806099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport.
    Hughes JM; Tattersall MH
    Br J Cancer; 1989 Mar; 59(3):381-4. PubMed ID: 2930702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potentiated antitumor effect of methotrexate by dipyridamole].
    Cao SS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):7-12. PubMed ID: 2527632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines.
    Smith PG; Marshman E; Calvert AH; Newell DR; Curtin NJ
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):63-7. PubMed ID: 10598557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipyridamole potentiates the in vitro activity of MTA (LY231514) by inhibition of thymidine transport.
    Smith PG; Marshman E; Newell DR; Curtin NJ
    Br J Cancer; 2000 Feb; 82(4):924-30. PubMed ID: 10732767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.
    Grem JL; Fischer PH
    Cancer Res; 1985 Jul; 45(7):2967-72. PubMed ID: 4005834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of dipyridamole action by alpha 1 acid glycoprotein. Reduced potentiation of quinazoline antifolate (CB3717) cytotoxicity by dipyridamole.
    Curtin NJ; Newell DR; Harris AL
    Biochem Pharmacol; 1989 Oct; 38(19):3281-8. PubMed ID: 2818627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.
    Weber G; Nagai M; Prajda N; Nakamura H; Szekeres T; Olah E
    Cancer Commun; 1991 Apr; 3(4):127-32. PubMed ID: 2025497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.